Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-03-01 @ 10:11 AM
Study NCT ID:
NCT01807156
Status:
TERMINATED
Last Update Posted:
2016-04-22
First Post:
2013-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Sponsor:
Emory University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB00061422
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |